AMEREN CORP

For the period ended Sep 30, 2026. Filed Nov 6, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 6, 2026

AEE$114.02+1.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheet

	September 30,2026	December 31, 2025
ASSETS
Current Assets:
Cash and cash equivalents	$40	$13
Accounts receivable – trade (less allowance for doubtful accounts of $47 and $39, respectively)	853	665
Unbilled revenue	511	415
Miscellaneous accounts receivable	238	107
Inventories	873	774
Current regulatory assets	275	387
Other current assets	329	210
Total current assets	3,119	2,571
Property, Plant, and Equipment, Net	42,239	39,313
Investments and Other Assets:
Nuclear decommissioning trust fund	1,638	1,526
Goodwill	411	411
Regulatory assets (includes $426 and $443 related to VIEs, respectively)	2,964	2,524
Pension and other postretirement benefits	1,000	977
Other assets	1,396	1,154
Total investments and other assets	7,409	6,592
TOTAL ASSETS	$52,767	$48,476
LIABILITIES AND EQUITY
Current Liabilities:
Current maturities of long-term debt (includes $24 and $23 related to VIEs, respectively)	$1,574	$973
Short-term debt	496	643
Accounts and wages payable	976	1,254
Taxes accrued	235	66
Interest accrued	199	229
Customer deposits	244	238
Other current liabilities	469	504
Total current liabilities	4,193	3,907
Long-term Debt, Net (includes $414 and $426 related to VIEs, respectively)	20,443	18,214
Deferred Credits and Other Liabilities:
Accumulated deferred income taxes and tax credits, net	5,646	5,181
Regulatory liabilities	6,606	6,255
Asset retirement obligations	863	849
Other deferred credits and liabilities	680	540
Total deferred credits and other liabilities	13,795	12,825
Commitments and Contingencies (Notes 2, 9, and 10)
Shareholders’ Equity:
Common stock, $.01 par value, 400.0 shares authorized – shares outstanding of 276.9 and 276.4, respectively	3	3
Other paid-in capital, principally premium on common stock	8,149	8,106
Retained earnings	6,017	5,292
Accumulated other comprehensive income	38	—
Total shareholders’ equity	14,207	13,401
Noncontrolling Interests	129	129
Total equity	14,336	13,530
TOTAL LIABILITIES AND EQUITY	$52,767	$48,476

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.